MEDICINOVO
MEDICINOVO is a medical company that provides artificial intelligence personalized medication system.
MEDICINOVO
Industry:
Artificial Intelligence Health Care Medical Pharmaceutical
Founded:
2017-03-01
Address:
Fengtai, Beijing, China
Country:
China
Website Url:
http://www.medicinovo.com
Total Employee:
11+
Status:
Active
Contact:
010-62662756
Total Funding:
18 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Apache Mobile Non Scaleable Content Nginx PHP Apache 2.4 DigiCert SSL
Similar Organizations
Metronet Co., Ltd.
Metronet Co., Ltd. offers Doctor search, medical-related services, artificial intelligence, medical information & pharmaceuticals services.
mfine
Mfine is a health-tech startup developing an AI-powered telemedicine mobile app.
Current Employees Featured
Jie Zhao Chief Executive Officer & Founder @ MEDICINOVO
Chief Executive Officer & Founder
Founder
Official Site Inspections
http://www.medicinovo.com
- Host name: 123.57.151.186
- IP address: 123.57.151.186
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "MEDICINOVO"
诺道医学
诺道医学以“集数据之力，助人类健康”为使命，与多家知名大型三甲医院合作，以先进的大数据人工智能技术，聚焦用药合理安全，形成临床药学与慢病辅助诊断人工智能整体解决方案。 …See details»
MEDICINOVO - Crunchbase Company Profile & Funding
MEDICINOVO is a medical artificial company that provides clinically rational drug use and has formed a real-world data network based on joint laboratories. It offers software that helps …See details»
公司简介 - 诺道医学 - medicinovo.com
诺道医学以“让人人用药无忧”为使命，聚焦感染、心脑血管疾病、呼吸系统疾病、精神疾病、癫痫、移植后/自身免疫性疾病和肿瘤等患者临床精准用药和多重用药管理的需求（临床急需，填补重大疾病诊疗手段空白；政策所指，新增医疗服务 …See details»
Medicinovo Company Profile 2024: Valuation, Funding & Investors …
Information on valuation, funding, cap tables, investors, and executives for Medicinovo. Use the PitchBook Platform to explore the full profile.See details»
MEDICINOVO - Products, Competitors, Financials, Employees, …
MEDICINOVO is a medical artificial intelligence company operating in the healthcare sector. The company offers advanced big data AI technology solutions focusing on the rational and safe …See details»
MEDICINOVO - Contacts, Employees, Board Members, Advisors
MEDICINOVO has 1 current employee profile, Chief Executive Officer & Founder Jie Zhao. MEDICINOVO is a medical company that provides artificial intelligence-based personalized …See details»
MEDICINOVO - Funding, Financials, Valuation & Investors
MEDICINOVO is a medical company that provides artificial intelligence-based personalized medication systems.See details»
公司简介 - 诺道医学
北京诺道认知医学科技有限公司是医疗人工智能新锐企业，国家高新技术企业，中国医师协会智慧医疗专委会委员单位、中国卫生信息与健康医疗大数据学会老年医学大数据专委会常委单位。 …See details»
产品介绍 - 诺道医学 - medicinovo.com
IPharma药物治疗管理系统是借鉴美国药师协会药物治疗管理 (Medication Therapy Management，MTM)流程、结合国内药学门诊和居家药学服务的应用场景而开发的多功能用药管理系统。 本系统具有全面和持续更新的各类药学知识库，覆 …See details»
MediciNova, Inc. (MediciNova, Inc.) - 药物管线_专利_临床试验_投 …
FebroScan is a non-invasive, quantitative, and accurate measure of liver fat content commonly used in early phase trials to measure treatment response. Secondary endpoints include safety …See details»
MediciNova Announces New Data and Results of a Phase 2
Nov 19, 2023 · MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic, and …See details»
Company - MediciNova, Inc.
MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet …See details»
MN-166 - MediciNova, Inc.
MN-166 is a first-in-class, orally bioavailable, small molecule glial attenuator that suppresses pro-inflammatory cytokines IL-1ß, TNF-a, and IL-6, and may upregulate the anti-inflammatory …See details»
MEDICINOVO - Tech Stack, Apps, Patents & Trademarks
MEDICINOVO is a medical company that provides artificial intelligence-based personalized medication systems.See details»
Working at MediciNova - Glassdoor
Glassdoor gives you an inside look at what it's like to work at MediciNova, including salaries, reviews, office photos, and more. This is the MediciNova company profile. All content is posted …See details»
Personalized venlafaxine dose prediction using artificial ... - Springer
May 11, 2024 · Venlafaxine dose regimens vary considerably between individuals, requiring personalized dosing. This study aimed to identify dose-related influencing factors of …See details»
Home - MediciNova, Inc.
MediciNova is a biopharmaceutical company that is developing novel therapeutics with a primary focus on neurology, respiratory, and liver diseases with unmet medical needs.See details»
Effectiveness of ulinastatin in critical care patients in real world: a ...
Oct 1, 2024 · We aimed to evaluate the effectiveness of ulinastatin based on a real-world database in the intensive care unit (ICU) patients. This was a retrospective cohort study. ICU …See details»
MN-001 - MediciNova, Inc.
Previously, MediciNova evaluated MN-001 for its potential clinical efficacy in asthma and had positive Phase 2 results. MN-001 has been exposed to more than 600 subjects and …See details»
List of medical organizations - Wikipedia
Africa Centres for Disease Control and Prevention; AMD Alliance International; European Centre for Disease Prevention and Control; International College of Angiology [1]; International …See details»